Also known as the partial remission phase, this period is characterized by residual pancreatic beta-cell functionality of a small portion of the remaining pancreatic beta cells, temporarily reducing the need for exogenous insulin.17 During this phase, diabetes education and frequent insulin dose adjustment are critical to prevent ketoacidosis, as highlighted by the mother of a T1DM teenage participant. The gene discussed is INS; the disease is diabetes mellitus.